Predictors and Outcomes of Immune Effector Cell Associated Neurotoxicity Syndrome in Patients Receiving Chimeric Antigen Receptor T-Cell Therapy for Aggressive B-Cell Non-Hodgkin Lymphoma

被引：0
|
作者：
Patel, Vivek [1 ]
Bhaskar, Shakthi [1 ]
Schuster, Stephen J. [2 ]
Nastoupil, Loretta J. [3 ]
Perales, Miguel-Angel [4 ]
Shouval, Roni [4 ]
McGuirk, Joseph P. [5 ]
Maziarz, Richard T. [6 ]
Chen, Andy [7 ]
Bachanova, Veronika [8 ]
Porter, David L. [2 ]
Bishop, Michael R. [9 ]
Riedell, Peter A. [9 ]
Oluwole, Olalekan O. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Univ Penn, Div Hematol Oncol, Dept Med, Philadelphia, PA USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA
[4] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplant Serv, Cellular Therapy Serv, Dept Med, New York, NY USA
[5] Univ Kansas Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS USA
[6] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA
[7] Oregon Hlth & Sci Univ, Ctr Hematol Malignancies, Knight Canc Inst, Portland, OR USA
[8] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[9] Univ Chicago, David & Etta Jonas Ctr Cellular Therapy, Chicago, IL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165556
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
    Yin, Zixun
    Zhang, Ya
    Wang, Xin
    [J]. BIOMARKER RESEARCH, 2021, 9 (01)
  • [2] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
    Zixun Yin
    Ya Zhang
    Xin Wang
    [J]. Biomarker Research, 9
  • [3] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
    Hamilton, Mark P.
    Miklos, David B.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
  • [4] Chimeric Antigen Receptor T-Cell Therapy for Companion Canines with Spontaneous B-Cell Non-Hodgkin Lymphoma
    O'Connor, Colleen M.
    Olivares, Simon
    Ang, Sonny
    Champlin, Richard E.
    Wilson-Robles, Heather M.
    Cooper, Laurence J. N.
    [J]. MOLECULAR THERAPY, 2013, 21 : S249 - S249
  • [5] Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
    Roy, Ishan
    Smilnak, Gordon
    Burkart, Madelyn
    Hamilton, Elizabeth
    Thorp, Katherine
    Miyata, Sarah
    Ma, Shuo
    Pro, Barbara
    Winter, Jane
    Gordon, Leo
    Karmali, Reem
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (01) : 71 - 75
  • [6] Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas
    Anagha Deshpande
    William Rule
    Allison Rosenthal
    [J]. Current Treatment Options in Oncology, 2022, 23 : 89 - 98
  • [7] Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas
    Deshpande, Anagha
    Rule, William
    Rosenthal, Allison
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (01) : 89 - 98
  • [8] Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomas
    Johnson, P. Connor
    Abramson, Jeremy S.
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2561 - 2567
  • [9] Immune Effector Cell-Associated Neurotoxicity Syndrome Related to Chimeric Antigen Receptor T-Cell Therapy
    San Martin, Alejandro Herrero
    Alcala, Juan
    Gonzalez, Maialen
    Velilla Alonso, Gabriel
    Martins, Guilherme
    Romero Coronado, Juan
    [J]. NEUROLOGY, 2024, 102 (08)
  • [10] Risk stratification for immune effector cell-associated neurotoxicity syndrome in patients receiving chimeric antigen receptor T cell therapy
    Chishinga, Nathaniel
    Mapalo, Martha Tendai
    Bodine, Charles Douglas, Jr.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345